2576 — Zhejiang Taimei Medical Technology Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.91bn
- HK$722.09m
- CNY551.16m
Annual cashflow statement for Zhejiang Taimei Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -480 | -423 | -356 | -217 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 155 | 41 | -25.8 | 93.3 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 71.1 | -3.21 | -21 | -117 |
| Change in Accounts Receivable | ||||
| Change in Other Assets | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -218 | -329 | -351 | -202 |
| Capital Expenditures | -32.4 | -28.2 | -9.48 | -5.68 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -347 | 22.3 | 247 | -278 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -379 | -5.88 | 238 | -284 |
| Financing Cash Flow Items | -7.72 | 320 | -8.5 | -5.31 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -40.1 | 286 | -39.3 | 281 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -645 | -12.6 | -149 | -199 |